Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
8.32
-0.60 (-6.73%)
At close: Dec 2, 2025, 4:00 PM EST
8.37
+0.05 (0.60%)
After-hours: Dec 2, 2025, 7:47 PM EST
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $607.25 million as of December 2, 2025. Its market cap has increased by 140.38% in one year.
Market Cap
607.25M
Enterprise Value
492.95M
1-Year Change
140.38%
Ranking
Category
Stock Price
$8.32
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $607.25M, an increase of 123.79%. That is a compound annual growth rate of 47.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 651.05M | 199.13% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |